ADRENALINE RENAUDIN 0,50 mg/ml, solution injectable, ADRENALINE RENAUDIN 1 mg/ml, solution injectable en ampoule clinical trials

Impact of low dose epinephrine in the management of out-of-hospital cardiac arrest on neurological outcome: A multicenter randomized and double-blind trial (Low-EPI Study)

This study, called Low-EPI, is looking at whether a lower dose of adrenaline (epinephrine) given to people who have a sudden cardiac arrest outside of a hospital can help them recover better, especially with their brain function, compared to the usual dose. We want to see if it improves their health after 28 days.